Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hunt

Showing results (951-960 of 1,059) with videos related to

Pageof 106
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancerT M Breslin, L Cohen, A Sahin, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
BMC Cancer|September 26, 2018
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcomaEmily Z Keung, Alexander J Lazar, Keila E Torres, et al.
Annals of Surgical Oncology|February 6, 2016
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic SarcomaChristina L Roland, Caitlin D May, Kelsey L Watson, et al.
JAMA Oncology|March 28, 2025
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical TrialHenry M Kuerer, Vicente Valero, Benjamin D Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapyThomas A Buchholz, Angela Katz, Eric A Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)Judy C Boughey, Kari M Rosenkranz, Karla V Ballman, et al.
Turkish Journal of Anaesthesiology and Reanimation|September 5, 2017
WHO Needs High FIO<sub>2</sub>?Ozan Akca, Lorenzo Ball, F Javier Belda, et al.
Annals of Surgical Oncology|September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomasJennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
Pageof 106

Showing results (951-960 of 1,059) with videos related to

Sort By:
Pageof 106
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancerT M Breslin, L Cohen, A Sahin, et al.
Annals of Surgery|January 7, 2011
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi, Thomas A Buchholz, Funda Meric-Bernstam, et al.
BMC Cancer|September 26, 2018
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcomaEmily Z Keung, Alexander J Lazar, Keila E Torres, et al.
Annals of Surgical Oncology|February 6, 2016
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic SarcomaChristina L Roland, Caitlin D May, Kelsey L Watson, et al.
JAMA Oncology|March 28, 2025
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical TrialHenry M Kuerer, Vicente Valero, Benjamin D Smith, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapyThomas A Buchholz, Angela Katz, Eric A Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)Judy C Boughey, Kari M Rosenkranz, Karla V Ballman, et al.
Turkish Journal of Anaesthesiology and Reanimation|September 5, 2017
WHO Needs High FIO<sub>2</sub>?Ozan Akca, Lorenzo Ball, F Javier Belda, et al.
Annals of Surgical Oncology|September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomasJennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
Annals of Surgical Oncology|January 22, 2013
Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experienceKristelle Lusby, Kari Brewer Savannah, Elizabeth G Demicco, et al.
Pageof 106